Reuter U, Goadsby P, Lanteri-Minet M, et al. Efficacy and safety of erenumab in episodic migraine patients with 2-4 prior preventive treatment failures: Results from the Phase 3b LIBERTY study. AAN 2018, emerging science abstract 009.
Addendum richtlijn ‘Ziektemodulerende behandeling van Multiple Sclerose bij volwassenen’
nov 2020 | Multipele Sclerose